ERs associate with and regulate the production of caveolin: Implications for signaling and cellular actions

Molecular Endocrinology

Volumn 16, Issue 1, 2002, Pages 100-115

  Razandi, Mahnaz ^b   Oh, Philip ^d   Pedram, Ali ^b   Schnitzer, Jan ^d   Levin, Ellis R ^a,b,c  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; BLOOD VESSEL INJURY; BREAST CANCER; CELL GROWTH; CELL MEMBRANE; CELL STRAIN MCF 7; HUMAN; HUMAN CELL; MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0036139164     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.16.1.0757     Document Type: Article

References (60)

1. Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors
2. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription
3. Nongenomic effects of 17β-estradiol on maturing human oocytes: Relationship to oocyte developmental potential
4. Phospholipase Cβ and membrane action of calcitriol and estradiol
5. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells
6. Cell membrane and nuclear estrogen receptors derive from a single transcript: Studies of ERα and ERβ expressed in CHO cells
7. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
8. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons
9. Plasma membrane estrogen receptors signal to anti-apoptosis in breast cancer
10. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
11. Estrogen receptor-α detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry
12. Estrogen and progesterone inhibit human vascular smooth muscle proliferation
13. The protective effects of estrogen on the cardiovascular system
14. Association of the Ras to mitogen-activated protein kinase signal transduction pathway with microfilaments. Evidence for a p185(neu)-containing cell surface signal transduction particle linking the mitogenic pathway to a membrane-microfilament association site
15. Separation of caveolae from associated microdomains of GPI-anchored proteins
16. Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases
17. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane
18. The caveolae membrane system
19. Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31)
20. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae
21. Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains
22. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins
23. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling
24. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium
25. Immunoisolation of caveolae with high affinity antibody binding to the oligomeric caveolin cage. Toward understanding the basis of purification
26. p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase A signaling cascades transcriptionally down-regulates caveolin-1 promoter activity
27. Multiple domains in caveolin-1 control its intracellular traffic
28. Detergent-resistant membrane microdomains from Caco-2 cells do not contain caveolin
29. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity
30. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation
31. Estrogen receptor α rapidly activates the IGF-1 receptor
32. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, gpr30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF
33. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane
34. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae
35. Regulation of cellular signalling by fatty acid acylation and prenylation of signal transduction proteins
36. 2+calmodulin and caveolin
37. The endothelial nitric-oxide synthase-caveolin regulatory cycle
38. Estrogen receptor α and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae
39. Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization
40. A cytoplasmic inhibitor of the JNK signal transduction pathway
41. The JIP group of mitogen-activated protein kinase scaffold proteins
42. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
43. Estrogen signals to preservation of endothelial cell form and function
44. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3): Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1
45. Reduction of caveolin and caveolae in oncogenically transformed cells
46. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade
47. Hyperexpression of mitogen-activated protein kinase in human breast cancer
48. Caveolin-1 potentiates estrogen receptor α (ERα) signaling. Caveolin-1 drives ligand-independent nuclear translocation and activation of ERα
49. Caveolin-1 interacts with androgen receptor: A positive modulator of androgen receptor mediated transactivation
50. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the Golgi complex
51. A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo
52. Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase: Consequences for catalysis
53. Src tyrosine kinases, Gα subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases
54. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development
55. Mitogen-activated protein kinase cascades as regulators of stress responses
56. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets
57. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1
58. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice
59. Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
60. Prostaglandins PGE2 and prostacyclin inhibit ET-1 secretion from endothelial cells by activating the particulate form of cGMP